Epoetin (EPO)

100 - Epoetin (EPO) (Rev. 1, 10-01-03) SNF-543 EPO is a biologically engineered protein which stimulates the bone marrow to make new red blood cells. Patients with anemia associated with chronic renal failure include all ESRD patients regardless of whether they are on dialysis. EPO is covered for the treatment of anemia for patients with chronic renal failure who are receiving dialysis when it is administered in a renal dialysis facility (RDF). EPO is not included in SNF PPS and may be billed separately when given in conjunction with dialysis by the Renal Dialysis Facility. It must be billed by the RDF. EPO is not a SNF outpatient benefit.